Chris Schelling

Insider Reports History

Location
Cambridge, MA
Signature
/s/ Harry S. Palmin, as Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Chris Schelling:

Company Role Class Num Shares Value Price $ Report Date Ownership
Acer Therapeutics Inc. PRESIDENT AND CEO, Director, 10%+ Owner Common Stock 2,712,529 $3,309,285 $1.22 29 Nov 2022 Direct
Acer Therapeutics Inc. PRESIDENT AND CEO, Director, 10%+ Owner Common Stock, $0.0001 par value per share 0 17 Nov 2023 Direct

Insider Reports Filed by Chris Schelling

Symbol Company Period Transactions Value $ Form Type Role Filing Time
/report/000089924323020440-schelling-chris-2023-11-17 Acer Therapeutics Inc. 17 Nov 2023 1 $0 4 PRESIDENT AND CEO, Director, 10%+ Owner 20 Nov 2023, 17:03
/report/000120919122059174-schelling-chris-2022-11-29 Acer Therapeutics Inc. 29 Nov 2022 1 +$1,000,000 4 President & CEO, Director, 10%+ Owner 01 Dec 2022, 15:02
/report/000120919122003729-schelling-chris-2022-01-14 Acer Therapeutics Inc. 14 Jan 2022 1 $0 4 President & CEO, Director, 10%+ Owner 19 Jan 2022, 15:29